Revisiting Novartis versus Natco – Cancer drugs, divisional applications and patent validity

The Delhi High Court upheld the validity of Novartis’s Ceritinib patent against Natco’s challenge, addressing divisional application issues and allegations of suppression. The injunction against Natco remains in force, reinforcing the enforceability of Novartis’s patent rights.

Read more about Revisiting Novartis versus Natco – Cancer drugs, divisional applications and patent validity

Novartis Trademark JALRA to be acquired for 200 crores, Private Company Acquires .Org Registry and more

USV Pvt Ltd will acquire the JALRA trademark from Novartis for 200 crores as the patent for Vildagliptin expires. The bulletin also discusses major updates in domain name disputes, brand licensing, and the GI tag awarded to Khola Chilli.

Read more about Novartis Trademark JALRA to be acquired for 200 crores, Private Company Acquires .Org Registry and more

Voting Machine Patent, Delhi High Court restrains Natco, Samsung and Huawei settle patent dispute and more

The latest patent news analyses trends in Indian patent filings and grants, key court orders, and major patent settlements. It includes updates on the voting machine patent, Novartis’s litigation, and industry statistics.

Read more about Voting Machine Patent, Delhi High Court restrains Natco, Samsung and Huawei settle patent dispute and more